Clinical trial of antidiabetic traditional medicine formulation (TMF) No. 32
No Thumbnail Available
Date
1994-04-01
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Clinical trial to determine the therapeutic efficacy of a traditional antidiabetic drug, TMF-32, was carried out on six Type II NIDDM patients who were admitted to the Traditional Medicine Hospital, Yangon. All patients, 3 males and 3 females, had a fasting blood glucose level of more than 150 mg percent (205.2 + 35.6) and a 2 hour post-prandial blood glucose level of more than 200 mg percent (323.0 + 62.09) and were clinically free from complications of diabetes. The study was a complete cross-over design, using tolbutamide as a control and was conducted under strict diabetic diet wupplying approximately 2500 kcals per day. Hypoglycaemic efficacy calculated from oral glucose tolerance test (OGTT) curves indicated that TMF-32, at doses of 2G and 3G, significantly reduces the blood glucose levels in these patients (p < 0.01 in both doses). The maximum hypoglycaemic effect was seen at approximately 2 hours after dosing and the duration of action lasted only up to 6 hours. Construction of log. dose-response curves showed TMF-32 of having a hypoglycaemic potency of 73 percent of tolbutamide but frequent side effects and cost of drug give rise to contradicting questions on whether it may be useful as a standard traditional antidiabetic drug.
Description
Keywords
Citation
Thaw Zin, Nwe Nwe Win, Win Myint, Khin Aye Than, Tin Mi Mi Naing, Aung Naing, Kyaw Sein, Maung Maung Wint. Clinical trial of antidiabetic traditional medicine formulation (TMF) No. 32. Myanmar Health Sciences Research Journal. 1994; 6(1): 11-18